eli lilly

Amylin Pharmaceuticals says a federal court issued an injunction preventing drug development partner Eli Lilly from using the same sales force to sell an Amylin-developed diabetes treatment and a competitor's.

Drugmaker Eli Lilly says it will buy Avid Radiopharmaceuticals in a deal that could be worth up to $800 million.

The company is facing losing patent protection on drugs that accounted for 74 percent of its sales in 2009, a decline considered to be the worst patent cliff facing major companies in the industry.

Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.

Eli Lilly still expects its earnings per share to grow in the double-digit range through 2011 and says it plans to launch two new medicines per year starting in 2013.

There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.

Drugmaker Eli Lilly & Co. says it will eliminate thousands of jobs and reorganize into five business units in an effort to slash costs and speed up development of potential new drugs.

A federal court ruling that invalidated a patent protecting Eli Lilly and Co.'s cancer drug Gemzar surprised at least one analyst covering the company but stirred little reaction from investors in trading Tuesday.

The Food and Drug Administration has approved a highly anticipated blood thinner from Eli Lilly after more than 18 months of review.

Collaboration, automated data collection chores expedite delivery of new products.